Information:
Error:
ID
14568
Description
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02144675
Link
https://clinicaltrials.gov/show/NCT02144675
Keywords
Versions (1)
- 4/21/16 4/21/16 -
Uploaded on
April 21, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT02144675
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT02144675
- StudyEvent: Eligibility
Similar models
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT02144675
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
aml
Item
patients must have a diagnosis of non-m3 aml (patients with m3 subtype are excluded); determination of the presence of cytogenetic abnormalities will be by standard cytogenetics +/- fluorescent-in-situ (fish) studies; additional molecular analyses for nucleophosmin (npm) mutation and fms-related tyrosine kinase 3 (flt3) internal tandem duplication will be obtained as a part of standard care by institutional procedures
boolean
C0023467 (UMLS CUI [1])
leukemic blast count
Item
leukemic blast count > 1500/mm^3 of peripheral blood
boolean
C2697913 (UMLS CUI [1])
eastern cooperative oncology group (ecog) performance status
Item
patients must have an eastern cooperative oncology group (ecog) performance status =< 3
boolean
C1520224 (UMLS CUI [1])
total bilirubin
Item
total bilirubin < 2 times the institutional upper limit of normal (uln)
boolean
C0201913 (UMLS CUI [1])
aspartate aminotransferase
Item
aspartate aminotransferase (ast) (serum glutamic oxaloacetic transaminase [sgot]) < 3 times the institutional uln
boolean
C0201899 (UMLS CUI [1])
serum creatinine
Item
serum creatinine < 1.5 times the institutional uln
boolean
C0201976 (UMLS CUI [1])
Left ventricular ejection fraction
Item
multi gated acquisition scan (muga) or echocardiogram with left ventricular ejection fraction (lvef) > 50%
boolean
C0428772 (UMLS CUI [1])
negative pregnancy test
Item
women of childbearing potential must have a negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
psychiatric illness
Item
no uncontrolled psychiatric illness that the principal investigator feels will compromise obtaining informed consent from a patient
boolean
C0004936 (UMLS CUI [1])
informed consent
Item
patient must be informed of the investigational nature of this study and must give written informed consent in accordance with institutional and federal guidelines; patients who do not provide informed consent will not be eligible for the study
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
any coexisting medical condition or medications precluding full compliance with any of the arms of the study
boolean
C0525058 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,2])
allergies to any investigational drugs
Item
allergies to any investigational drugs and/or to the chemotherapeutic agents
boolean
C0020517 (UMLS CUI [1,1])
C0729502 (UMLS CUI [1,2])
C0729502 (UMLS CUI [1,2])
allergies to any non-steroidal anti-inflammatory drugs
Item
allergies to any non-steroidal anti-inflammatory drugs (nsaids)/salicylates (e.g., aspirin)
boolean
C0020517 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C0003211 (UMLS CUI [1,2])
gastrointestinal hemorrhage
Item
endoscopically documented upper or lower gastrointestinal (gi) related hemorrhage within last 6 months; also, patients with a clinical diagnosis of gi bleeding requiring blood transfusions will be excluded
boolean
C0017181 (UMLS CUI [1])